Recently, intrinsic PD-L1 signaling has been shown to also play a critical role in promoting tumor progression, metastasis, immune evasion, and inducing responsiveness to anti-PD-(L)1 immunotherapy via a PD-1 dependent or independent means [54,55,56,57]. The gene discussed is CD274; the disease is neoplasm.